SNCA and Parkinson disease: Gastrointestinal dysfunction is connected to PD and several approaches have been developed to alleviate α-synuclein pathological effects, such as therapeutic strategies to stimulate gastric motility (Moore et al., 2018), use of antibiotics and microbiota replacement (Fasano et al., 2015; Felice et al., 2016).